Clinical Trials Directory

Trials / Conditions / Childhood Solid Neoplasm

Childhood Solid Neoplasm

8 registered clinical trials studyying Childhood Solid Neoplasm.

StatusTrialSponsorPhase
CompletedNanoparticle Albumin-Bound Rapamycin, Temozolomide, and Irinotecan Hydrochloride in Treating Pediatric Patient
NCT02975882
Children's Oncology GroupPhase 1
CompletedPrexasertib in Treating Pediatric Patients With Recurrent or Refractory Solid Tumors
NCT02808650
Children's Oncology GroupPhase 1
CompletedGene-Modified T Cells, Vaccine Therapy, and Nivolumab in Treating Patients With Stage IV or Locally Advanced S
NCT02775292
Jonsson Comprehensive Cancer CenterPhase 1
CompletedTalazoparib and Temozolomide in Treating Younger Patients With Refractory or Recurrent Malignancies
NCT02116777
National Cancer Institute (NCI)Phase 1 / Phase 2
CompletedCrizotinib and Combination Chemotherapy in Treating Younger Patients With Relapsed or Refractory Solid Tumors
NCT01606878
Children's Oncology GroupPhase 1
CompletedTivantinib in Treating Younger Patients With Relapsed or Refractory Solid Tumors
NCT01725191
National Cancer Institute (NCI)Phase 1
CompletedSorafenib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Leukemia
NCT01445080
National Cancer Institute (NCI)Phase 1 / Phase 2
CompletedCollecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With
NCT00898079
Children's Oncology Group—